Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6550)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2017 (publication date) through Jul 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhu HT, Ai DS, Tang HR, Badakhshi H, Fan JH, Deng JY, Zhang JH, Chen Y, Zhang Z, Xia Y, Guo XM, Jiang GL, Zhao KL. Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma. World J Gastroenterol 2017; 23(3): 540-546 [PMID: 28210091 DOI: 10.3748/wjg.v23.i3.540] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i3/540.htm |
| Number | Citing Articles |
| 1 |
He‐Yuan Hsieh, Chung‐Ping Hsu, Hui‐Ling Yeh, Cheng‐Yen Chuang, Jai‐Fu Lin, Chen‐Fa Chang. Definite intensity‐modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally‐advanced or inoperable esophageal squamous cell carcinoma. The Kaohsiung Journal of Medical Sciences 2018; 34(5): 281 doi: 10.1016/j.kjms.2017.12.005
|
| 2 |
Huiping Zhu, Xiaoling Lu, Jian Jiang, Jingfeng Lu, Xinchen Sun, Yun Zuo. Radiotherapy Combined With Concurrent Nedaplatin-Based Chemotherapy for Stage II–III Esophageal Squamous Cell Carcinoma. Dose-Response 2022; 20(1): 155932582210767 doi: 10.1177/15593258221076720
|
| 3 |
Alex Ritter, Cooper Quartermaine, Jovan Pierre-Charles, Suryakumar Balasubramanian, Pejman Raeisi-Giglou, Daniel Addison, Eric Miller. Cardiotoxicity of Anti-Cancer Radiation Therapy: a Focus on Heart Failure. Current Heart Failure Reports 2023; 20(1): 44 doi: 10.1007/s11897-023-00587-0
|
| 4 |
Xuejiao Ren, Lan Wang, Chun Han, Leiming Ren. Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma. Radiotherapy and Oncology 2018; 129(2): 293 doi: 10.1016/j.radonc.2018.09.006
|
| 5 |
Yilin Yu, Hongying Zheng, Lingyun Liu, Hui Li, Qunhao Zheng, Zhiping Wang, Yahua Wu, Jiancheng Li. Predicting Severe Radiation Esophagitis in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: Construction and Validation of a Model Based in the Clinical and Dosimetric Parameters as Well as Inflammatory Indexes. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.687035
|
| 6 |
Qiong Yi, Canyu Liu, Yingshan Cui, Yanguang Yang, Yaqi Li, Xingwen Fan, Kailiang Wu. Chemoradiotherapy with paclitaxel liposome plus cisplatin for locally advanced esophageal squamous cell carcinoma: A retrospective analysis. Cancer Medicine 2023; 12(6): 6477 doi: 10.1002/cam4.5416
|
| 7 |
Dobrina Tsvetkova, Stefka Ivanova. Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases. Molecules 2022; 27(8): 2466 doi: 10.3390/molecules27082466
|
| 8 |
Huiping Zhu, Xiaolin Ge, Yufeng Lu, Yun Zuo, Qin Qin, Xinchen Sun, Min Yang. Nedaplatin‑based chemotherapy regimens combined with concurrent radiotherapy as first‑line treatment for stage II‑III esophageal squamous cell carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9564
|
| 9 |
Wen-Xiu Ding, Shu Liu, Jian-Xin Ma, Juan Pu, Hai-Jing Wang, Shu Zhang, Xin-chen Sun. Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0752-y
|
| 10 |
Chunhui Zheng, Xiaomei Chen, Fangbiao Zhang, Liping Yan, Xiangyan Zhang. Surgery combined with radio-chemotherapy for esophageal mucoepidermoid carcinoma. Medicine 2018; 97(24): e11165 doi: 10.1097/MD.0000000000011165
|
| 11 |
Junhe Zhang, Weihua Dong. Lentiviral-Mediated Beclin-1 Overexpression Inhibits Cell Proliferation and Induces Autophagy of Human Esophageal Carcinoma Eca109 Cell Xenograft in Nude Mice. Recent Patents on Anti-Cancer Drug Discovery 2020; 15(1): 70 doi: 10.2174/1574892814666191211130342
|